1. Introduction {#s0005}
===============

Alzheimer\'s disease (AD) is characterized by a cascade of complex pathophysiologic processes including deposition of amyloid-beta plaques, accumulation of tau in the form of neurofibrillary tangles, and neurodegeneration. Because of the close association between tau pathology, neurodegeneration and cognitive impairment ([@bb0105]), there is increasing interest in the development of positron emission tomography (PET) tracers that bind specifically to tau ([@bb0135]). \[^18^F\]THK5317 is a well-characterized tau-specific tracer ([@bb0050]; [@bb0100]; [@bb0065]; [@bb0015]), showing high retention in patients with AD with a regional uptake pattern matching that of the distribution of tau pathology described by post-mortem studies ([@bb0010]). There has been some concern about binding of tau tracers such as the structurally related tracer \[^18^F\]THK5351 to monoamine oxidase-B (MAO-B) present in astrocytes ([@bb0095]). A recent *in vitro* study of the racemic compound \[^3^H\]THK5117 showed relatively low affinity to monoamine oxidase-B indicating that competitive binding of the corresponding (*S*)-enantiomer \[^18^F\]THK5317 would not present a problem at the concentrations encountered during clinical PET studies ([@bb0070]), although *in vivo,* an off target binding is evident in the basal ganglia ([@bb0010]).

Use of tau imaging in clinical practice for diagnostic purposes, study of disease progression and evaluation of drug treatment effects, as well as in research investigations with PET, is facilitated by short scans and simplified analysis methods. Previous studies, however, have shown a poor correlation between static standardized uptake value ratio (SUVR) at various late time intervals and binding potential BP~ND~ based on dynamic scans with \[^18^F\]THK5317 in AD patients ([@bb0050]). The optimal time for assessment of SUVR, in terms of its agreement with the non-displaceable binding potential (BP~ND~)~,~ is at peak specific binding, or transient equilibrium (TE), when theoretically SUVR-1 equals BP~ND~ ([@bb0045]). However, for all tau tracers of which, to our knowledge, tracer kinetic studies in humans have been described (\[^18^F\]THK5317 ([@bb0050]), \[^18^F\]THK5351 ([@bb0075]), \[^18^F\]AV-1451 ([@bb0020]; [@bb0030]), \[^18^F\]MK6240 ([@bb0085])) TE is reached at different time points throughout the brain, resulting in a spatially varying bias in SUVR values compared to BP~ND~ values. In addition to being spatially varying, binding characteristics in regions with tau accumulation will change over time This may result in a disease progression-dependent bias in SUVR, complicating between group comparison of SUVR values in both cross-sectional and longitudinal studies.

In addition to measures of tau accumulation, dynamic \[^18^F\]THK5317 can also provide estimates of the relative tracer delivery (R~1~), the ratio between K~1~ in the target and reference region, reflecting relative regional cerebral blood flow if extraction in both region is similar. A recent study has shown that \[^18^F\]THK5317 R~1~ values demonstrate a high correlation to \[^18^F\]FDG cerebral glucose metabolism ([@bb0115]). However, in that study, the R~1~ values were only validated using a scan length of 60 min and use of R~1~ possibly based on shorter scan durations, matching the optimal timing for SUVR measurements, needs to be validated.

A step to further simplify the analysis method is the availability of an automatic way to define the reference region volume of interest (VOI) directly from the dynamic PET data, without the need of a structural MRI or the use of manual VOI delineation. One approach for this is the supervised cluster analysis (SVCA) method. The SVCA algorithm segments voxels in the dynamic PET volume based on their time activity curves (TACs) with no spatial constraint, *i.e.* the whole brain is considered. Voxels with kinetic behaviour most resembling the TACs of the proposed reference region are included in the reference VOI. The SVCA method has been suggested as an automatic way of extracting a reference region in previous studies for *(R)-*\[^11^C\]PK11195 ([@bb0130]; [@bb0140]), \[^11^C\]PIB ([@bb0040]), *(R)-*\[^11^C\]rolipram ([@bb0090]), \[^11^C\]TMSX ([@bb0110]) and \[^11^C\]PE2I ([@bb0055]). Although the principles of an implementation of the SVCA algorithm are similar for each tracer, this method needs to be validated for \[^18^F\]THK5317.

The purpose of the present work was to determine time to TE for various brain regions, to quantify the time-depending biases in different tissues for healthy controls (HC) and AD patients, and to establish the optimal time window for measurement of SUVR and R~1~ of \[^18^F\]THK5317. In addition, the present work aimed to validate a SVCA method for automatic extraction of a reference TAC directly from the dynamic \[^18^F\]THK5317 data.

2. Methods {#s0010}
==========

2.1. Subjects {#s0015}
-------------

Data from 18 subjects, including nine AD patients and nine HCs included in a previously published study ([@bb0050]; [@bb0010]) was used in the present work. Eight of the subjects (4 AD and 4 HC) were included to serve as a separate set of data for the definition of kinetic classes in the SVCA algorithm. Patient characteristics were previously described in detail ([@bb0010]). All subjects signed an informed consent before inclusion and the Regional Board of Medical Ethics in Stockholm and the Medical Radiation Ethics Committee at Uppsala University Hospital approved the study.

2.2. Data acquisition {#s0020}
---------------------

The radiosynthesis of \[^18^F\]THK5317, the *(S)*-enantiomeric form of \[^18^F\]THK5117, has been described previously ([@bb0050]). All subject underwent a \[^18^F\]THK5317 PET scan on an ECAT Exact HR+ scanner (Siemens, Knoxville) ([@bb0005]). After a 10 min transmission scan with rotating ^68^Ge rod sources, the scan was started simultaneously with the injection of 3 MBq/kg \[^18^F\]THK5317. Ten of the subjects (five AD and five HC) underwent a 90 min dynamic PET scan (25 frames; 6 × 10, 3 × 20, 2 × 30, 2 × 60, 2 × 150, 4 × 300, and 6 × 600 s), while the remaining subjects underwent a 60 min dynamic scan (22 frames; 6 × 10, 3 × 20, 2 × 30, 2 × 60, 2 × 150, 4 × 300, and 3 × 600 s). These last 8 subjects were only used for definition of the kinetic classes applied in SVCA. Images were reconstructed using normalisation- and attenuation-weighted ordered subsets expectation maximisation (6 iterations, 8 subsets) with a 4 mm Hanning post-filter, applying all appropriate corrections for attenuation, scatter, randoms, *etc.*, as included in the scanner software. In addition, all subjects underwent a T1-weighted structural MRI scan.

2.3. Volumes of interest {#s0025}
------------------------

Dynamic PET images were corrected for motion using frame-by-frame realignment in Voiager software (GE Healthcare, Uppsala, Sweden). The T1-weighted MRI scans were co-registered to a summation image (0--5 min) of their corresponding PET volume and segmented into grey matter, white matter and CSF using SPM8 (Wellcome Trust Center for Neuroimaging, University College London, UK). VOIs were defined on the MRI images using a probabilistic atlas (PVElab)([@bb0125]) and projected onto the dynamic PET images to extract regional TACs. VOIs included in the analysis were: midbrain, hippocampus, amygdala, thalamus, putamen, sensory motor, occipital, entorhinal, frontal, temporal and parietal cortex Left and right side VOIs were averaged. In addition, a white matter VOI and a whole brain grey matter VOI were included, and a grey matter cerebellar VOI as reference region.

2.4. Optimal timing {#s0030}
-------------------

DVR-1 values were calculated on a VOI-basis, using the reference Logan method (30--90 min) ([@bb0080]) with cerebellar grey matter as reference tissue, which was previously shown to agree well with plasma input-based analysis ([@bb0050]). For each VOI, the time at which TE occurred was determined as the peak of the specific binding curve, calculated by subtraction of the grey matter cerebellum TAC from the VOI TAC. To account for differences in the delivery between target regions and cerebellum, the target TAC was scaled by the ratio of the radioactivity concentrations in cerebellum and target between 1 and 2 min post-injection (p.i). Noise-induced peaks in specific binding at early time points (\<15 min) were avoided by only allowing TE values larger than 15 min. SUVR-1 was calculated for all VOIs for seven consecutive fixed 20 min intervals between 10 and 90 min p.i., in steps of 10 min, as well as for a 20 min interval centred around TE. Correlation and bias between SUVR-1 values for the various time intervals and DVR-1 were calculated using linear regression. Cohen\'s d was calculated as the difference between the means of both groups (AD patients and HCs) divided by the pooled standard deviation. This was calculated for both SUVR-1 values at TE and different time intervals, as well as DVR-1, in amygdala, parietal-, temporal- and entorhinal cortex. This gives the effect size expressed in number of pooled standard deviations and gives a further indication of the ability to discriminate between the two groups for different time intervals of the calculations.

Parametric SUVR-1 images for the fixed time intervals were generated, and DVR-1 images were constructed using the reference Logan method (30--90 min). In addition, time to TE images were computed based on specific binding curves estimated using receptor parametric mapping (RPM) ([@bb0025]), which is a basis function implementation of the simplified reference tissue model (SRTM) ([@bb0060]).

2.5. Supervised cluster analysis {#s0035}
--------------------------------

A set of four kinetic classes were predefined on dynamic \[^18^F\]THK5317 data from eight subjects (4 AD and 4 HC) that were specifically included for this purpose only: cerebellar grey matter, grey matter, white matter and a blood pool class. The cerebellum class was defined on the HC subjects, to ensure that only healthy tissue was included, using the VOIs generated with PVElab for each subject. The grey matter, white matter and blood pool classes were defined on the AD patients; grey matter and white matter were defined using the PVElab VOIs and the blood pool class was defined as voxels with a value higher than 20% of the maximum voxel value during the initial 60 s (frame 1--6) on the 10 most caudal slices. The definition of the classes other than cerebellum was aimed at avoiding inclusion of their associated voxels in the cerebellum class*.* The TACs from each class were normalized to their respective area under the curve. The SVCA algorithm, specific for \[^18^F\]THK5317, was implemented in Matlab (Mathworks, Natick MA).

To generate reference time-activity curves for the 5 AD patients and the 5 HC subjects included in the validation of the method, TACs of each voxel in the dynamic data sets were normalized to their area under the curve. A non-negative least-squares algorithm was used to find a linear combination of the probability for each voxel to correspond to each kinetic class. Four different thresholds, as a limit of the probability of the voxels to belong to a class, were investigated: 0.3, 0.4, 0.5 and 0.6. Voxels with a probability higher than the threshold were assigned to that specific class. The voxels selected for the cerebellum class were regarded as reference region and a mean of the TACs of the selected voxels was calculated to extract a reference TAC. The SVCA-extracted reference TAC was then used as input function to generate new parametric SUVR-1 images for the optimal time window as well as R~1~ images using RPM. RPM was implemented with 100 basis functions predefined for each scan, with discrete values for the exponential variable ranging from 0.005 to 0.5 min^−1^, and R~1~ was calculated using data ranging from the start of the scan to the end of the optimal time window for SUVR measures. Regionally averaged voxel values of the 11 VOIs were extracted from the SUVR-1 images and compared with the SUVR-1 values calculated using an MRI-based cerebellum reference for the optimal timing. Similarly, values extracted from RPM R~1~ parametric images were compared with regional SRTM R~1~ generated for the full 90 min scan duration with an MRI-based reference. Values were compared using linear regression and the square of the correlation coefficient (R^2^). In addition, Cohen\'s d was calculated between the AD and HC groups for the SUVR-1 values of the optimal time window in amygdala, parietal-, temporal- and entorhinal cortex.

3. Results {#s0040}
==========

3.1. Optimal timing {#s0045}
-------------------

Mean parametric images of reference Logan DVR-1 and SUVR-1 for time intervals of 20--40 and 70--90 min, are given in [Fig. 1](#f0005){ref-type="fig"} for the AD and HC groups. There is an obvious overestimation of SUVR-1 values compared to DVR-1, and an increase of SUVR-1 with increasing time.Fig. 1Mean \[^18^F\]THK5317 reference Logan DVR-1 and SUVR-1 images for the 20--40 and 70--90 min intervals for the AD patients and the HCs.Fig. 1

[Fig. 2](#f0010){ref-type="fig"}(a) shows parametric maps of the mean time to TE in AD and HC subjects, as well as the difference between the two groups. The parametric maps clearly show the decreased time to TE in AD patients in occipital, parietal and sensory motor cortices. [Fig. 2](#f0010){ref-type="fig"}(b) shows mean time to TE for all investigated VOIs. For AD patients, TE was reached first in the putamen, frontal- and parietal cortex at 22 ± 4 min (mean ± SD), whereas in HCs, TE was reached first in putamen at 20 ± 0 min. In AD, TE in temporal cortex was reached at 24 ± 5 min. TE was reached last in occipital cortex for both AD patients and HCs at 52 ± 23 and 80 ± 0 min respectively. Mean time to TE across the whole brain was 30 ± 0 min in AD and 42 ± 4 min in HC (p \< .05).Fig. 2(a) Mean time to transient equilibrium in AD patients and healthy controls, as well as difference in time to transient equilibrium between the groups. (b) Mean time to transient equilibrium for all investigated regions in the two groups. \* denotes a significant difference between AD and HC (Mann-Whitney test, p \< .05).Fig. 2

[Fig. 3](#f0015){ref-type="fig"} shows correlation (a-b) and bias (c-d) between SUVR-1 and DVR-1 for AD and HC subjects, as well as the difference in bias between AD and HC (d), for all investigated regions. Over all regions and subjects, SUVR-1 on a time interval centred around 30 or 40 min showed a high correlation with DVR-1 (R^2^ = 0.97 and 0.95 respectively for both AD patients and for HC). The lowest mean bias for the fixed intervals was found for the 20--40 min time interval (2% for both AD and HC). This suggests an overall preference for an SUVR time window centred around 30 min, both in terms of correlation and bias relative to DVR-1. In HCs, there is a clear grouping in bias in two groups of regions, with cortical regions showing less bias and less time dependence of bias than limbic regions and putamen. This difference is less obvious in the AD group. Use of SUVR~TE~-1 resulted in somewhat lower correlations with DVR-1 (R^2^ = 0.87 and 0.86 in AD and HC, respectively), but a bias equal to the 20--40 min time interval (2%) in AD patients. The bias in SUVR is higher in AD patients than in HC and difference in bias between the groups is generally smallest for a window centred around 30 min p.i.Fig. 3Correlation between SUVR-1 at various time intervals with DVR-1 in (a) HC and (b) AD; absolute bias of SUVR-1 relative to DVR-1 in (c) HC and (d) AD; and (e) difference in bias relative to DVR-1 between AD and HC.Fig. 3

Cohen\'s d of DVR-1 and SUVR-1 at TE and different time intervals, for amygdala, parietal-, temporal- and entorhinal cortex, between AD patients and HCs are shown in [Fig. 4](#f0020){ref-type="fig"}. For time windows centring at 30 min and higher, Cohen\'s d was close to constant in parietal-, temporal- and entorhinal cortices, with the highest values, around 5, for parietal cortex. In the amygdala, Cohen\'s d showed a continuing increase for increasing time after injection even at 80 min p.i.Fig. 4Cohen\'s d as a function of DVR-1 and SUVR-1 at TE and different time intervals for parietal-, temporal-, entorhinal cortex and amygdala between AD patients and HCs.Fig. 4

3.2. Supervised cluster analysis {#s0050}
--------------------------------

Since an overall preference for SUVR calculation was found for a time window centred around 30 min, *i.e.* 20--40 min, only this interval was used when investigating the SVCA for SUVR and a total scan duration of 0--40 min for R~1~ measures.

Mean residual sum of squares (RSS) for all subjects was lowest for a threshold of 0.3 and increased with increasing thresholds. The correlation between SUVR-1 with MRI and SVCA-based reference regions were highest for thresholds of 0.4 and 0.5 (R^2^ = 0.93 and 0.94, respectively). Given that the lowest bias was seen using the 0.5 threshold (0.01) this threshold was chosen for further evaluation.

The normalized TACs of the predefined classes used in the SVCA algorithm are given in [Fig. 5](#f0025){ref-type="fig"}(a). [Fig. 5](#f0025){ref-type="fig"}(b) shows the MRI-based cerebellum reference region obtained using PVELab. [Fig. 5](#f0025){ref-type="fig"}(c) shows the reference region extracted using SVCA and VOIs of the remaining SVCA classes are given in [Fig. 5](#f0025){ref-type="fig"}(d). All regions are examples from one AD patient. The MRI-based reference VOI are clearly limited to cerebellum, while the SVCA-reference VOI also included voxels outside the cerebellum, due to similar kinetics of \[^18^F\]THK5317 in these regions as in the cerebellum. No voxels corresponding to the blood class were included, and therefore only grey and white matter VOIs are shown in [Fig. 5](#f0025){ref-type="fig"}(d), probably due to high extraction of the tracer and noise in individual blood voxels.Fig. 5(a) The predefined kinetic classes used for SVCA as normalized time activity curves, (b) MRI-based cerebellum reference region, (c) reference region extracted using SVCA and (d) grey matter (purple) and white matter (orange) cluster extracted using SVCA where (b-d) are examples from one AD patient. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig. 5

High correlation and agreement was found between SUVR-1 with MRI-based and SVCA-based reference TACs in a 20--40 min interval (R^2^ = 0.93, slope = 0.95), as shown in [Fig. 6](#f0030){ref-type="fig"}(a) and (c). High agreement was also found between R~1~ using SRTM, 90 min of data, and MRI-based reference and R~1~ using RPM, 40 min of data, and SVCA-based reference (R^2^ = 0.94 and slope = 1.02), as shown in [Fig. 6](#f0030){ref-type="fig"}(b) and (d). Parametric \[^18^F\]THK5317 SUVR-1 and R~1~ images with MRI-based and SVCA-based reference are shown in [Fig. 7](#f0035){ref-type="fig"} for one AD patient and one HC, and are visually very similar for both SUVR-1 and R~1~.Fig. 6Relationship between (a) SUVR-1 using the 20--40 min interval with MRI-based cerebellum reference and SVCA-based reference, (b) between 90 min SRTM R~1~ with MRI-based cerebellum reference and 40 min RPM R~1~ with SVCA-based reference and (c-d) the corresponding Bland-Altman plots.Fig. 6Fig. 7Example of one HC and one AD patient. On the top row: SUVR-1 of the 20--40 min interval with MRI-based cerebellum reference and the SVCA-based reference and on the bottom row: 90 min R~1~ with MRI-based cerebellum reference and 40 min R~1~ with SVCA-based reference.Fig. 7

Cohen\'s d of SUVR-1 20--40 min with SVCA-based reference, between AD patients and HCs, were 1.04 in amygdala, 3.68 in parietal cortex and 2.55 in both temporal- and entorhinal cortex. This is in high agreement with the Cohen\'s d values for the MRI-based SUVR-1 20--40 min (± 10%), except in parietal cortex where Cohen\'s d was 4.82 when using the MRI-based reference region.

4. Discussion {#s0055}
=============

In this study, optimal timing for \[^18^F\]THK5317 SUVR-1 values, as well as a supervised clustering method to extract a reference region for generation of parametric SUVR-1 and R~1~ images were evaluated. Previous work has shown that SUVR-1 using a late time window greatly overestimates tau binding. To address this issue, time to TE and time-dependent bias were calculated in several brain regions. SUVR-1 was also calculated based on fixed time windows on several consecutive 20 min intervals.

The highly varying time to TE across the brain and between AD and HC groups complicates the definition of a generally applicable static scan interval. However, overall, \[^18^F\]THK5317 SUVR-1 values correlated and agreed best with DVR-1 values for the 20--40 min interval, both in AD and HCs. Although use of SUVR values at time of TE for each individual VOI leads to equal agreement with DVR-1 in AD patients as for the 20--40 min interval, correlation with DVR-1 was worse than for SUVR~20--40~-1 and SUVR-1 at an early fixed interval is preferred in terms of both feasibility and robustness. SUVR~20--40~-1 allows for optimal semi-quantitative assessment of tau pathology using a single, clinically feasible, 20 min scan. Lockhart and co-workers ([@bb0075]) found that SUVR over the time interval 40--60 min gave the most stable results, when compared to DVR, for \[^18^F\]THK5351. However, they did not assess the magnitude of bias when other intervals were chosen, and only looked at differences between AD and HC within this 40--60 min window. Similar investigations on regional time to TE as presented in this work have been performed for \[^18^F\]AV-1451, also showing a high variation across regions ([@bb0035]). In some regions, there were also large variations in TE between subjects, for example in occipital- and sensorimotor cortex in AD patients and frontal- and entorhinal cortex in HCs. This lead to a substantial lower correlation between DVR-1 and SUVR-1 at TE than at any of the fixed time intervals.

As [Fig. 3](#f0015){ref-type="fig"}(e) shows, SUVR-1 demonstrates a higher bias in AD patients than in controls in all regions except the midbrain and hippocampus for time intervals later than 40 min, and this difference increases with time. Although variability in SUVR-1 in terms of reduced correlation with DVR-1 also increases with time, the larger relative bias does lead to a better effect size for SUVR-1 values at later time points than for early time points and for DVR-1 in certain regions. For example, Cohen\'s d in the amygdala increases from 1.3 to 1.9 for SUVR-1 windows of 20--40 and 70--90 min, respectively, compared to 2.0 for DVR-1.

It has recently been shown that administration of a selective MAO-B inhibitor decreased the brain signal of \[^18^F\]THK5351, resulting in an overall decrease of SUVR in some cases, although similar reduction of \[^18^F\]THK5351 binding in cerebellum may mask this effect.([@bb0095]) Although this effect has not been demonstrated for \[^18^F\]THK5317, it would not be unlikely that similar effects may be found for this tracer too, based on the structural similarity and high striatal uptake of both tracers. However, as mentioned in the introduction, *in vitro* studies could not show this effect at concentrations relevant to *in-vivo* studies with \[^18^F\]THK5317. Although the results of the present work are not directly applicable to other tau tracers because of differing kinetics, similar issues are likely to be encountered for all other published tau tracers, as mentioned in the introduction, and the optimal window for static imaging should be assessed carefully for each tracer.

SUVR-1 measurements with an SVCA-based reference showed a high agreement to SUVR-1 values with MRI-based reference. SVCA can thus serve as a method to provide a reference TAC directly from the dynamic \[^18^F\]THK5317 scan. Even though an MRI in many cases is performed anyway in AD patients, an automatic way of extracting a reference region can still simplify the analysis of dynamic PET data. In addition, since the SVCA method yields a reference region with homogenous kinetics, it may be important in other types of brain injuries with associated tau pathology, such as in patients suffering from brain trauma where the cerebellum may be impaired and cannot be used as reference tissue, and in neurodegenerative diseases where cerebellum is also affected by tau accumulation, such as corticobasal degeneration. In [Fig. 6](#f0030){ref-type="fig"}(a) there is a clear line of outliers, all corresponding to the same subject, showing a positive bias in SUVR-1 values when using an SVCA-based reference. This overestimation in SUVR-1 values is due to a poor match of the SVCA reference TAC to the MRI-based cerebellar TAC. In this particular subject, the overestimation would have been reduced if a lower threshold value for inclusion in the reference TAC had been used. A way to further optimize the SVCA algorithm would be to have an individually adaptive threshold, which will be explored in further studies. A possible bias in the implementation of the SVCA is using a total grey matter VOI as one of the cluster classes since it consists of voxels with different amount of specific binding, including regions with no tau accumulation. This will impact the shape of the curve to more resemble the cerebellum curve. However, as seen in [Fig. 5](#f0025){ref-type="fig"}(a) there is still a large deviation between the normalized grey matter and cerebellum TACs and since the cluster classes other than cerebellum are only used to avoid inclusion of non-reference voxels in the cerebellum class, this issue is of minor importance. The predefined kinetic classes are based on a rather small group of subjects (4 HC and 4 AD). However, the variation between the normalized tissue curves is small, especially in the cerebellum.

As Rodriguez-Vieitez and co-workers showed, dynamic \[^18^F\]THK5317 can measure both tau accumulation as well as R~1~, an estimate of the relative cerebral blood flow, with high correlation to \[^18^F\]FDG uptake ([@bb0115]). As demonstrated in the present work, a scan duration of 40 min is sufficient to measure R~1~ using RPM and an SVCA-based reference. Although glucose metabolism and blood flow are obviously not identical measures, dual assessment of binding and relative cerebral blood flow could have clinical value. The possibility of dual-biomarker measurement with \[^18^F\]THK5317 could potentially serve as a substitute for \[^18^F\]FDG investigations, reducing the number of scans for the patients, and a shorter 40 min scan duration could further facilitate clinical use. In theory, BP~ND~ of the shorter scan duration could also have been investigated using RPM. However, 40 min was not enough to obtain robust BP~ND~ estimates on a voxel level, so this approach was not further investigated.

A possible challenge when using SVCA is that the characteristics of the PET scanner and the reconstruction method may affect the relative shapes of the TACs, making data acquisition and pre-processing routines important. This may complicate the use of such a method in multi-centre studies. A limitation in this study is the low number of subjects included and further studies are needed with patients with pathologies other than AD, where time-dependent bias may vary and the optimal static scan time window may be different.

5. Conclusion {#s0060}
=============

\[^18^F\]THK5317 SUVR-1 correlates best to DVR-1 and shows the lowest bias for a time interval of 20--40 min. Use of later scanning times will induce spatially-varying biases in binding estimates and result in overestimation of tau expression in AD patients relative to HCs. High agreement was found between SUVR-1 values, as well as R~1~ values, generated with MRI-based cerebellum reference and SVCA-based reference using a 40 min dynamic scan. This suggests that the SVCA method can be used to automatically extract a reference region TAC directly from dynamic \[^18^F\]THK5317 PET studies.
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